APH vs SER · P/E 40, rev $23.09B vs rev $56.0K
Amphenol Corporation (APH) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the APH and SER stock pages for the full models.
Not investment advice.